Patent ID: 11884958
Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Field: Basic materials chemistry (Chemistry)
Classification: CPC C  F | IPC C

Claim 0:
1. A method for treating a mammal having a functional gastrointestinal disorder (FGID) using a targeted treatment approach, wherein said method comprises:
(a) identifying said mammal as having a small intestinal microbiome (i) comprising two or more microbes selected from group A consisting of Anaeroglobus species, Erwinia species, Escherichia species, Staphylococcus species, Scardovia species, Bifidobacterium species, Lactobacillus species, Olsenella species, Slackia species, and Shuttleworthia species; and (ii) comprising reduced levels of two or more microbes selected from group B consisting of Lachnoanaerobaculum species, Prevotella species, Leptotrichia species, Catonella species, Gemella species, Neisseria species, Haemophilus species, and Streptococcus species; and
(b) administering a probiotic to said mammal, wherein said probiotic comprises one or more of said microbes selected from said group B that were identified as having said reduced levels in said step (a).